Peru isn't just showing up to listen. It's positioning itself as a player.
In the halls of global health governance in Geneva, Peru arrived not merely as a participant but as a nation with hard-won expertise to offer. At the 79th World Health Assembly, Health Minister Juan Carlos Velasco engaged the world's top health leadership on the enduring challenges of vaccination, primary care, and tuberculosis—a disease that continues to claim hundreds of thousands of lives each year. Peru's recognition as a board member of the Stop TB Partnership signals that a country's credibility on the world stage is built not through declarations, but through the slow, difficult work of managing disease where it actually lives.
- Drug-resistant tuberculosis remains one of global health's most stubborn crises, and Peru has been fighting it on the ground long enough to earn a seat at the table where solutions are shaped.
- Health Minister Velasco's bilateral meeting with WHO Director-General Tedros Adhanom Ghebreyesus put Peru's vaccination program and health regulation enforcement at the center of a high-level diplomatic exchange.
- A separate meeting with Stop TB Partnership chief Lucica Ditiu moved beyond strategy into concrete steps—tighter disease control and more reliable access to the medicines that actually work.
- Peru's technical cooperation director joined international discussions on keeping tuberculosis drugs affordable and available, confronting the unglamorous but critical problem of supply chains and pricing.
- Across every meeting, Peru's delegation sent a consistent signal: this country is not observing the global health conversation—it is shaping it.
In Geneva this May, Peru's Health Minister Juan Carlos Velasco used the 79th World Health Assembly to pursue a focused diplomatic agenda, meeting with WHO Director-General Tedros Adhanom Ghebreyesus to advance three priorities: strengthening Peru's national vaccination program, improving primary health care delivery, and reinforcing the mechanisms that enforce international health regulations. These are not bureaucratic abstractions—they are the infrastructure that determines whether disease is contained or allowed to spread.
Tuberculosis dominated much of Peru's agenda. Velasco met with Stop TB Partnership director Lucica Ditiu to discuss concrete measures for tightening disease control and improving patient access to effective treatments. Drug-resistant strains have made TB increasingly difficult to manage, and the conversation reflected the urgency of a problem that kills hundreds of thousands annually.
Peru's depth of experience in managing drug-resistant tuberculosis earned the country formal recognition: a seat on the Stop TB Partnership board. The position is substantive, not ceremonial, reflecting a track record that the global health community now looks to as a model. Meanwhile, Alberto Tejada, head of Peru's international technical cooperation office, participated in separate discussions on ensuring tuberculosis medicines remain affordable and consistently available—a challenge as complex as it sounds simple.
The Health Ministry framed the assembly as part of a broader strategy to deepen Peru's integration into the international health system. The country arrived in Geneva with experience, credibility, and a clear message: it has both the expertise and the stakes to help lead on the problems that matter most.
In Geneva this May, Peru's health minister Juan Carlos Velasco sat down with the director-general of the World Health Organization to talk about vaccines. It was one of several bilateral meetings Velasco held during the 79th World Health Assembly in Switzerland—a gathering where health officials and specialists from around the world convene to hash out the year's most pressing public health problems.
The conversation with Tedros Adhanom Ghebreyesus, WHO's top administrator, centered on three things Peru wants to strengthen: its national vaccination program, primary health care delivery, and the machinery needed to enforce international health regulations. These aren't abstract concerns. They're the backbone of how a country prevents disease from spreading across its borders and within its own population. The two officials also used the meeting to swap notes on broader health strategies and the global challenges that keep public health officials awake at night—disease prevention, emerging threats, the usual weight of the work.
But tuberculosis dominated Peru's agenda in Switzerland. The disease remains one of the world's most stubborn killers, and drug-resistant strains have made it even harder to treat. Velasco met with Lucica Ditiu, who leads Stop TB Partnership, an international coalition fighting the disease. They discussed concrete steps to tighten tuberculosis control and get better medicines to patients who need them. The conversation wasn't theoretical. Peru knows this terrain. The country has built real expertise in managing drug-resistant tuberculosis and has policies in place designed to strengthen its response to the disease.
That expertise earned Peru a seat on Stop TB Partnership's board—a recognition that came up during the assembly. It's not ceremonial. The board position reflects Peru's track record and signals to the global health community that the country has something to teach about fighting a disease that kills hundreds of thousands of people each year. Alberto Tejada, who runs Peru's international technical cooperation office, represented the ministry at a separate international event focused on making sure tuberculosis drugs stay affordable and available over the long term. It's a problem that sounds simple but isn't: how do you ensure that the medicines that work actually reach the people who need them, year after year, without the supply chain collapsing or prices climbing out of reach?
The Health Ministry framed these meetings as part of a larger strategy—one aimed at building sustainable solutions and deepening Peru's ties with the international health system. The 79th Assembly itself brought together the machinery of global health governance: ministers, experts, researchers, and advocates all trying to align on what matters most. For Peru, the message was clear: the country isn't just showing up to listen. It's positioning itself as a player, someone with real experience and real stakes in the problems being discussed. Tuberculosis, vaccination, the ability to respond when disease crosses a border—these are the threads that bind Peru's health diplomacy together.
Notable Quotes
These actions form part of a strategy oriented toward promoting sustainable solutions and strengthening international cooperation for the benefit of public health— Peru's Health Ministry
The Hearth Conversation Another angle on the story
Why does Peru need a seat at the table in Geneva? Isn't health a domestic issue?
Health doesn't stop at borders. A tuberculosis outbreak in one country becomes everyone's problem. Peru has learned how to manage drug-resistant strains—that knowledge matters globally, and Peru wants to shape how the world tackles the disease.
So this is about influence, then. Soft power through health.
It's partly that, but it's also practical. When Peru sits on Stop TB Partnership's board, it gets a voice in how resources are allocated, which treatments get prioritized, which countries get support. That directly affects Peruvian patients.
The minister met with the WHO director-general. What does that conversation actually accomplish?
It signals commitment and opens doors. When you sit down with Tedros, you're saying: we're serious about vaccination, we're serious about primary care, we want to implement international health rules properly. It's the kind of conversation that leads to funding, technical support, and partnerships that wouldn't happen otherwise.
And tuberculosis—why is that Peru's flagship issue?
Because Peru has lived with it. The country has real experience managing resistant strains and has built systems that work. That's not something you can fake. It's earned credibility.
What happens after the assembly ends?
The real work begins. Peru has to follow through on what it committed to—strengthening vaccination programs, improving primary care, making sure tuberculosis drugs stay accessible. The assembly is the announcement. The implementation is what matters.